Feed / Theme
Confirmed

Cancer Immunotherapy

4 names are moving together; 50% are participating in the current session.

Co-movement

Observed intraday paths are not available for this group yet.

Members

TICKERCompanySectorTodayObserved activity
SMMTSummit Therapeutics Inc.Healthcare-2.6%Group member
SNDXSyndax Pharmaceuticals, Inc.Healthcare-2.7%Most structurally connected
BNTXBioNTech SEHealthcare+1.7%Group member
XENEXenon Pharmaceuticals Inc.Healthcare+0.6%Group member

Why we believe this

Cohort

4 names

Participation

50% this session

Observed history

1 daily builds

Cancer Immunotherapy can stay leader-led if secondary names fail to join while SNDX keeps moving.

Connected, outside the group

No high-confidence filing-linked non-members are available for this group yet.

History

Historical cohort observations are not available yet.